Regeneron Research Facility
Regeneron Research Facility
Tarrytown, New York, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Participants | Advanced Non-small Cell Lung Cancer | Active, not recruiting | Not stated | 2026-09-10 | NCT06269133 |